Filing Details
- Accession Number:
- 0000899243-22-016320
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-03 16:28:33
- Reporting Period:
- 2022-04-29
- Accepted Time:
- 2022-05-03 16:28:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1847529 | Joy Liu | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-04-29 | 17 | $273.37 | 14,437 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-29 | 41 | $274.75 | 14,396 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-29 | 30 | $275.62 | 14,366 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-29 | 22 | $276.72 | 14,344 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-04-29 | 10 | $278.04 | 14,334 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
- Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
- Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
- Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).